"Navigating the Modern News Zoo so you don't have to."
Friday, May 30, 2025
ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death
For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related cancer compared with dipeptidyl peptidase-4 (DPP-4) inhibitors, according to a study scheduled to be presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.
š Full Story
Copās āBlack Fatigueā Gets Him in Trouble During Viral Arrest š¤Æ
- Germanyās Threats to Hungary and Slovakia Expose the EUās Globalist Authoritarian Drift, Say Fico and OrbĆ”n - Diana Zapata
- WATCH: Reform UK Mayor STORMS OUT of Interview After BRUTAL GRILLING ā Political KNIVES Are OUT in Shock Showdown - Isaiah Amos
- Opera's new 'fully agentic' browser can surf the web for you - Igor Bonifacic
- Advancement in AI: New Brain-Like Transistor Mimics Human Intelligence - Michael Terry
- Florida Appellate Court to Pulitzer Board: Stand Up And Take Your Medicine in Trump Defamation Case
- NASA has used supercomputers to learn when all life on Earth will end
The Real Truth About Nothing's Budget Phone! *30-Days Review*
- Getting a Shingles Vaccine May Also Protect Your Brain and Heart Health, Studies Suggest - Stephanie Anderson Witmer
- Bongino Claims New Video Evidence Will Prove Epstein Suicide, And āBagsā Of Improperly Stored Comey-Era Evidence Found - Diana Zapata
- The iPhone 5S has officially become obsolete. What does this mean for Apple enthusiasts and tech lovers? - Michael A. Medeiros
- ICE Nabs Illegal Migrant Who Got Probation For Hit-And-Run That Killed Colorado Woman - Hailey Gomez
- Disney+ launches fan perks with Disney Pinnacle by Dapper Labs - Dean Takahashi
- Google Lens is coming to YouTube Shorts - Anna Washenko
